IL126063A - Medicinal products containing ulanzapine for the treatment of migraine pain - Google Patents

Medicinal products containing ulanzapine for the treatment of migraine pain

Info

Publication number
IL126063A
IL126063A IL12606397A IL12606397A IL126063A IL 126063 A IL126063 A IL 126063A IL 12606397 A IL12606397 A IL 12606397A IL 12606397 A IL12606397 A IL 12606397A IL 126063 A IL126063 A IL 126063A
Authority
IL
Israel
Prior art keywords
olanzapine
migraine pain
medicament
treatment
treating migraine
Prior art date
Application number
IL12606397A
Other languages
English (en)
Hebrew (he)
Other versions
IL126063A0 (en
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL126063A0 publication Critical patent/IL126063A0/xx
Publication of IL126063A publication Critical patent/IL126063A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL12606397A 1996-03-25 1997-03-24 Medicinal products containing ulanzapine for the treatment of migraine pain IL126063A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1412796P 1996-03-25 1996-03-25
PCT/US1997/004471 WO1997035582A1 (en) 1996-03-25 1997-03-24 Method for treating migraine pain

Publications (2)

Publication Number Publication Date
IL126063A0 IL126063A0 (en) 1999-05-09
IL126063A true IL126063A (en) 2002-04-21

Family

ID=21763694

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12606397A IL126063A (en) 1996-03-25 1997-03-24 Medicinal products containing ulanzapine for the treatment of migraine pain

Country Status (17)

Country Link
US (1) US5929070A (pt)
EP (1) EP0932407A4 (pt)
JP (1) JP2001508759A (pt)
KR (1) KR20000004966A (pt)
CN (1) CN1106196C (pt)
AU (1) AU721290B2 (pt)
BR (1) BR9708145A (pt)
CA (1) CA2250186A1 (pt)
CZ (1) CZ298398A3 (pt)
EA (1) EA000769B1 (pt)
IL (1) IL126063A (pt)
NO (1) NO984432L (pt)
NZ (1) NZ332037A (pt)
PL (1) PL329221A1 (pt)
UA (1) UA44838C2 (pt)
WO (1) WO1997035582A1 (pt)
YU (1) YU42098A (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001517202A (ja) * 1996-03-25 2001-10-02 イーライ・リリー・アンド・カンパニー 痛み処置方法
IL126203A (en) * 1996-03-25 2002-12-01 Lilly Co Eli A synergistic painkiller that contains olenzapine and another painkiller
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
CA2507158A1 (en) * 2002-11-26 2004-06-10 Alexza Molecular Delivery Corporation Treatment of headache with antipsychotics delivered by inhalation
AU2003294470B2 (en) 2002-11-26 2009-09-17 Alexza Pharmaceuticals, Inc. Use of loxapine and amoxapine for the manufacture of a medicament for the treatment of pain
US20050079166A1 (en) 2003-05-21 2005-04-14 Alexza Molecular Delivery Corporation Self-contained heating unit and drug-supply unit employing same
DE112005000641T5 (de) 2004-09-06 2007-09-06 Shasun Chemicals and Drugs Ltd., Chennai Neues Verfahren zur Herstellung einer pharmazeutisch reinen polymorphen Form I von Olanzapin
ES2594867T3 (es) 2007-03-09 2016-12-23 Alexza Pharmaceuticals, Inc. Unidad de calentamiento para usar en un dispositivo de administración de fármaco
US11400048B2 (en) 2014-06-25 2022-08-02 Synergia Bio Sciences Private Limited Pharmaceutical oil-in-water nano-emulsion
WO2015198350A1 (en) 2014-06-25 2015-12-30 Synergia Bio Sciences Private Limited A pharmaceutical oil-in-water nano-emulsion

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
KR940701258A (ko) * 1991-06-21 1994-05-28 피터 죤 기딩즈 문맥압 항진증 및 편두통의 치료를 위한 테트라하이드로벤즈아제핀 유도체의 용도
DK206591D0 (da) * 1991-12-23 1991-12-23 Lundbeck & Co As H Behandling af psykoser
AU668159B2 (en) * 1992-05-29 1996-04-26 Lilly Industries Limited Pharmaceutical compounds
WO1995024200A1 (en) * 1994-03-11 1995-09-14 Eli Lilly And Company Method for treating 5ht2b receptor related conditions
US5457101A (en) * 1994-06-03 1995-10-10 Eli Lilly And Company Thieno[1,5]benzoidiazepine use
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine

Also Published As

Publication number Publication date
NO984432D0 (no) 1998-09-23
EA000769B1 (ru) 2000-04-24
NZ332037A (en) 2001-01-26
CA2250186A1 (en) 1997-10-02
CN1219876A (zh) 1999-06-16
YU42098A (sh) 1999-09-27
JP2001508759A (ja) 2001-07-03
CZ298398A3 (cs) 1999-06-16
EA199800864A1 (ru) 1999-02-25
IL126063A0 (en) 1999-05-09
AU2584597A (en) 1997-10-17
UA44838C2 (uk) 2002-03-15
US5929070A (en) 1999-07-27
EP0932407A4 (en) 2002-04-24
NO984432L (no) 1998-11-24
KR20000004966A (ko) 2000-01-25
BR9708145A (pt) 1999-07-27
AU721290B2 (en) 2000-06-29
PL329221A1 (en) 1999-03-15
EP0932407A1 (en) 1999-08-04
WO1997035582A1 (en) 1997-10-02
CN1106196C (zh) 2003-04-23

Similar Documents

Publication Publication Date Title
US5945416A (en) Method for treating pain
US5929070A (en) Method for treating migraine pain with olanzapine
US6258807B1 (en) Method for treating pain
AU709181B2 (en) Method for treating autism
AU734011B2 (en) Method for treating bipolar disorder
AU719517B2 (en) Method for treating excessive aggression
CA2248758A1 (en) Method for treating insomnia
CA2248905A1 (en) Method for treating bipolar disorder
MXPA98007431A (en) Medications to treat the bipo disorder
MXPA98007438A (en) Medications to treat the insom

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees